Special presentations will be made Sept. 24, 2-6 p.m. WHAT: A series of Featured Clinical Trials will be presented at Transcatheter Cardiovascular Therapeutics (TCT), in addition to late-breaking clinical trials. These featured clinical trials represent groundbreaking research and will yield data and insight that will further the field of interventional cardiology. WHEN: The TCT Featured Clinical Trials will be presented on September 24, 2009 from 2:00 – 6:00 pm.
Home » Featured Clinical Trials To Be Presented At Transcatheter Cardiovascular Therapeutics 2009 In San Francisco
In case you missed it
- GE HealthCare, AirStrip partner on patient monitoring, cardiac data visualization
- BD recalls more Alaris pumps due to compatibility issues with Cardinal Health syringes
- Aptar wins FDA contract to study low global warning potential metered dose inhalers
- Asensus makes another Senhance surgical robot sale
- Intuitive Ventures brings in $150M to support minimally invasive care startups
- Baxter has a Novum IQ infusion pump warning
- Eitan Medical’s Sapphire infusion pump recall is Class I
- Are investors overreacting on AtriCure after Medtronic’s Penditure launch?
- FDA warning doesn’t affect Embecta syringes, company says
- Nevro acquires joint fusion device maker Vyrsa, closes credit facility and refinancing
- Fast Five: J&J makes a $400M acquisition to enter LAA device space; U.S. lawmakers want SEC probe into Elon Musk’s Neuralink
- Metal Stamping for High-Volume, High-Precision, Medical Components & Assemblies
- Qnovia has positive results for inhaled smoking cessation therapy
- Procyrion enrolls first patient in IDE trial for mechanical circulatory support tech
- BD launches SiteRite vascular access ultrasound system
- Elon Musk denies Neuralink monkey death claims, U.S. lawmakers want SEC probe
- Johnson & Johnson MedTech enters LAA device space with acquisition of Laminar
From Medical Design & Outsourcing
- Study shows that electrodes implanted in the brain led to cognitive improvementsA study published in Nature demonstrated that implanted electrodes could provide a potential therapy for chronic brain injuries. Led by Dr. Nicholas Schiff, the study looked at five people with moderate to severe brain injuries. They received electrode implants in the brain and, with stimulation from the electrodes, saw improvements in cognitive performance. Researchers told The New… […]
- Millstone Medical Outsourcing plans testing services move to expanded facilityNEWS RELEASE: Millstone Medical Outsourcing Will Move Testing Services to Expanded Facility in Bloomfield, CT Move expands facility footprint by 400% and includes new testing services Fall River, MA – Millstone Medical Outsourcing, the industry’s leading partner of choice for medical manufacturers’ post-manufacturing and aftermarket services, announces that it will move its testing services division… […]
- Levita Magnetics hopes AI can take MARS robotic surgery platform to the next levelAfter winning FDA clearance to add robotics to its first-of-its-kind magnetic surgery system, Levita Magnetics is looking to artificial intelligence as the next big step. Mountain View, California-based Levita Magnetics designed the MARS system for high-volume abdominal surgeries such as laparoscopic bariatric surgeries, cholecystectomies (gallbladder removal), and prostate and colorectal procedures. “Our MARS system [allows]… […]
- Elevating Robotic Precision in Medical Devices: A Case Study by Omniseal Solutions™Unlock the secrets behind smoother robotic movements in medical devices with Omniseal Solutions™’ low friction sealing innovation. Our latest case study showcases how precision engineering meets medical excellence, ensuring optimal performance and reliability in robotic arm joints. By Clara Soueve Digital Customer Acquistion Specialist – Omniseal Solution™ Life Sciences Pioneering Low-Friction Seals for Robotic Arm… […]
- How Medtronic evaluates its exposure to GLP-1 drugsMedtronic Chief Scientific, Medical and Regulatory Officer Dr. Laura Mauri drills into GLP-1 drug trial results to estimate their impact across the portfolio. The impact of glucagon-like peptide-1 (GLP-1) drugs like Ozempic and Wegovy on medtech manufacturing is one of the biggest uncertainties heading into 2024. Industry leaders like Medtronic, Stryker and Intuitive have faced… […]
- Brain-computer interface lets ALS patient control home devicesResearchers say they observed the successful translation of brain signals into computer commands with a brain-computer interface (BCI) implant. A team at Johns Hopkins surgically implanted the BCI on the brain of an ALS (amyotrophic lateral sclerosis) patient. They published their results, which showed the accurate translation of computer commands from brain activity, in Advanced Science.… […]
- The 10 largest medtech employers of 2023 – and what their employees really thinkEmployees at the 10 largest medtech employers in the world are finding a greater balance between work and life but are still frustrated by corporate bureaucracy. Those are just a few takeaways as Medical Design & Outsourcing compiled employees’ sentiments from reviews posted on Glassdoor. Total medtech jobs were down year-over-year in our 2023 Medtech… […]
- Imperative Care CEO Fred Khosravi’s dream for medtech — and how to get thereMedtech leader Fred Khosravi is betting on an innovative — and risky — approach to patient care. Imperative Care co-founder, Chair and CEO Fred Khosravi, a refugee of the Iranian Revolution who became an engineer and serial entrepreneur in the U.S., wants medtech to shift its focus from treating diseases to treating patients. He’s taking… […]
- Can AI ‘move fast and cure things’ in healthcare?The entry of AI into healthcare is starkly different from the accepted adage of “move fast and break things” in consumerism. In episode 1 of AI Meets Life Sci, Kayleen Brown, managing editor at DeviceTalks, and Brian Buntz, pharma and biotech editor, discuss the opportunities, limitations, and direct impact of Ai in healthcare fields including… […]
- Mytos raises $19M Series A to automate human cell manufacturingNEWS RELEASE: Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth London, UK – November 30, 2023 – Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC. The… […]
- Moticont releases 0.875-in. diameter linear voice coil servo motorNEWS RELEASE: Linear Voice Coil Servo Motor Just 0.875 in. in Diameter Has High Force-to-Size High Acceleration, and a 0.25 in. Stroke! Van Nuys, CA – Moticont has released the GVCM-022-013-01 Linear Voice Coil Servo Motor. This compact .875 in. (22.2 mm) diameter high speed, high force-to-size linear motor features high accuracy and high repeatability… […]